+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Organ Transplant Market By Type (Living-donor transplant, Dead donor transplant), By Sex (Male, Female), By Product (Immuno-suppressant Drugs, Organ preservation solution, Organ Care System), By Organ, By Types of Transplant, By Region, Forecast & Opportunities, 2025

  • ID: 5022581
  • Report
  • May 2020
  • Region: Global
  • 119 pages
  • TechSci Research
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 3
The Global Organ Transplant Market is Expected to Grow at a Robust CAGR During the Forecast Period.

FEATURED COMPANIES

  • 21st Century Medicine
  • AstraZeneca
  • GE Healthcare
  • Lifeline Scientific
  • Organ Assist B.V
  • Pfizer
  • MORE
The Global Organ Transplant Market is expected to grow at a robust CAGR during the forecast period. Organ transplantation is basically the replacement of damaged or missing organs in the body with healthy ones. The market for organ transplant is driven by the growing old-age segment cross the world along with increasing cases of organ failures. Additionally, alcohol consumption has increased over the years, which usually damages the liver; thereby, positively impacting the organ transplant market. However, the market might be restrained due to the high cost of the organs that needs to be transplanted as they are really expensive, and the cost varies from country to country.

The Global Organ Transplant Market is segmented on the basis of type, sex, product, organ, types of transplant and region. The organ segment is further divided into lung, heart, liver, pancreas, intestine, kidney and others. Among these, kidney transplant is anticipated to account for the largest share in the market until 2025 as it has been proven to be the most successful transplant in the world. Also, increasing prevalence of renal diseases, globally is driving the growth of the segment.

Regionally, North America occupied the lion’s share in the Global Organ Transplant Market in 2019 by virtue of the increasing cases of organ failures and the ability of the region’s economy to provide enough funds to carry out organ transplantations. However, Asia-Pacific is anticipated to be one of the fastest growing regions as developing economies like India and China are still getting accustomed to organ transplants.

Leading players in the Global Organ Transplant Market include Novartis, Pfizer, Transmedics, Organ Recovery Systems, Sanofi, Transonic Systems Inc., XVIVO Perfusion, Transplant Biomedicals, Pharmaceuticals A/S, Organ Assist B.V, Essential Pharmaceuticals LLC., BioLife Solutions, Inc., Lifeline Scientific, 21st Century Medicine, Preservation solutions Inc., GE Healthcare, Sandor, Glaxosmith Kline, AstraZeneca, Amgen, etc.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025
Objective of the Study:
  • To analyze and forecast the market size of the Global Organ Transplant Market.
  • To classify and forecast the Global Organ Transplant Market based on type, sex, product, organ, types of transplant, region and company.
  • To identify drivers and challenges for the Global Organ Transplant Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Organ Transplant Market.
  • To conduct pricing analysis for the Global Organ Transplant Market.
  • To identify and analyze the profile of leading players operating in the Global Organ Transplant Market.
The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of hospitals/clinics across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the hospitals/clinics which could not be identified due to the limitations of secondary research. The author analyzed the hospitals/clinics, and presence of all major players across the globe.

The author calculated the market size of the Global Organ Transplant Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. They sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Organ transplant hospitals/clinics, laboratories, research institutes and other stakeholders
  • Pharmaceutical companies
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to organ transplant
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Organ Transplant Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Type:
  • Living-donor transplant
  • Dead donor transplant
Market, By Sex:
  • Male
  • Female
Market, By Product:
  • Immuno-suppressant Drugs
  • Organ preservation solution
  • Organ Care System
Market, By Organ:
  • Lung
  • Heart
  • Liver
  • Pancreas
  • Intestine
  • Kidney
  • Others
Market, By Types of Transplant:
  • Double Transplant
  • Single Transplant
Market, By Region:
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Russia
  • Spain
  • North America
  • United States
  • Mexico
  • Canada
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
Competitive Landscape
  • Company Profiles: Detailed analysis of the major companies present in the Global Organ Transplant Market.
Available Customizations:
With the given market data, researchers offers customizations according to a company’s specific needs.

This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 21st Century Medicine
  • AstraZeneca
  • GE Healthcare
  • Lifeline Scientific
  • Organ Assist B.V
  • Pfizer
  • MORE
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Organ Transplant Market

4. Voice of Customer

5. Executive Summary

6. Global Organ Transplant Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Type (Living-donor transplant, Dead donor transplant)
6.2.2. By Sex (Male, Female)
6.2.3. By Product (Immuno-suppressant Drugs, Organ preservation solution, Organ Care System)
6.2.4. By Organ (Lung, Heart, Liver, Pancreas, Intestine, Kidney and Others)
6.2.5. By Types of Transplant (Double transplant, Single transplant)
6.2.6. By Company (2019)
6.2.7. By Region
6.3. Market Attractiveness Index

7. Asia-Pacific Organ Transplant Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Sex
7.2.3. By Product
7.2.4. By Organ
7.2.5. By Types of Transplant
7.2.6. By Country
7.3. Market Attractiveness Index
7.4. Asia-Pacific: Country Analysis
7.4.1. China Organ Transplant Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Type
7.4.1.2.2. By Sex
7.4.1.2.3. By Product
7.4.1.2.4. By Organ
7.4.1.2.5. By Types of Transplant
7.4.2. India Organ Transplant Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Type
7.4.2.2.2. By Sex
7.4.2.2.3. By Product
7.4.2.2.4. By Organ
7.4.2.2.5. By Types of Transplant
7.4.3. Japan Organ Transplant Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Type
7.4.3.2.2. By Sex
7.4.3.2.3. By Product
7.4.3.2.4. By Organ
7.4.3.2.5. By Types of Transplant
7.4.4. South Korea Organ Transplant Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Type
7.4.4.2.2. By Sex
7.4.4.2.3. By Product
7.4.4.2.4. By Organ
7.4.4.2.5. By Types of Transplant
7.4.5. Singapore Organ Transplant Market Outlook
7.4.5.1. Market Size & Forecast
7.4.5.1.1. By Value
7.4.5.2. Market Share & Forecast
7.4.5.2.1. By Type
7.4.5.2.2. By Sex
7.4.5.2.3. By Product
7.4.5.2.4. By Organ
7.4.5.2.5. By Types of Transplant
7.4.6. Australia Organ Transplant Market Outlook
7.4.6.1. Market Size & Forecast
7.4.6.1.1. By Value
7.4.6.2. Market Share & Forecast
7.4.6.2.1. By Type
7.4.6.2.2. By Sex
7.4.6.2.3. By Product
7.4.6.2.4. By Organ
7.4.6.2.5. By Types of Transplant

8. Europe Organ Transplant Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Sex
8.2.3. By Product
8.2.4. By Organ
8.2.5. By Types of Transplant
8.2.6. By Country
8.3. Market Attractiveness Index
8.4. Europe: Country Analysis
8.4.1. France Organ Transplant Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Type
8.4.1.2.2. By Sex
8.4.1.2.3. By Product
8.4.1.2.4. By Organ
8.4.1.2.5. By Types of Transplant
8.4.2. Germany Organ Transplant Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Type
8.4.2.2.2. By Sex
8.4.2.2.3. By Product
8.4.2.2.4. By Organ
8.4.2.2.5. By Types of Transplant
8.4.3. United Kingdom Organ Transplant Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Type
8.4.3.2.2. By Sex
8.4.3.2.3. By Product
8.4.3.2.4. By Organ
8.4.3.2.5. By Types of Transplant
8.4.4. Italy Organ Transplant Market Outlook
8.4.4.1. Market Size & Forecast
8.4.4.1.1. By Value
8.4.4.2. Market Share & Forecast
8.4.4.2.1. By Type
8.4.4.2.2. By Sex
8.4.4.2.3. By Product
8.4.4.2.4. By Organ
8.4.4.2.5. By Types of Transplant
8.4.5. Russia Organ Transplant Market Outlook
8.4.5.1. Market Size & Forecast
8.4.5.1.1. By Value
8.4.5.2. Market Share & Forecast
8.4.5.2.1. By Type
8.4.5.2.2. By Sex
8.4.5.2.3. By Product
8.4.5.2.4. By Organ
8.4.5.2.5. By Types of Transplant
8.4.6. Spain Organ Transplant Market Outlook
8.4.6.1. Market Size & Forecast
8.4.6.1.1. By Value
8.4.6.2. Market Share & Forecast
8.4.6.2.1. By Type
8.4.6.2.2. By Sex
8.4.6.2.3. By Product
8.4.6.2.4. By Organ
8.4.6.2.5. By Types of Transplant

9. North America Organ Transplant Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Sex
9.2.3. By Product
9.2.4. By Organ
9.2.5. By Types of Transplant
9.2.6. By Country
9.3. Market Attractiveness Index
9.4. North America: Country Analysis
9.4.1. United States Organ Transplant Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Type
9.4.1.2.2. By Sex
9.4.1.2.3. By Product
9.4.1.2.4. By Organ
9.4.1.2.5. By Types of Transplant
9.4.2. Mexico Organ Transplant Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Type
9.4.2.2.2. By Sex
9.4.2.2.3. By Product
9.4.2.2.4. By Organ
9.4.2.2.5. By Types of Transplant
9.4.3. Canada Organ Transplant Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Type
9.4.3.2.2. By Sex
9.4.3.2.3. By Product
9.4.3.2.4. By Organ
9.4.3.2.5. By Types of Transplant

10. South America Organ Transplant Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Sex
10.2.3. By Product
10.2.4. By Organ
10.2.5. By Types of Transplant
10.2.6. By Country
10.3. Market Attractiveness Index
10.4. South America: Country Analysis
10.4.1. Brazil Organ Transplant Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Type
10.4.1.2.2. By Sex
10.4.1.2.3. By Product
10.4.1.2.4. By Organ
10.4.1.2.5. By Types of Transplant
10.4.2. Argentina Organ Transplant Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Type
10.4.2.2.2. By Sex
10.4.2.2.3. By Product
10.4.2.2.4. By Organ
10.4.2.2.5. By Types of Transplant
10.4.3. Colombia Organ Transplant Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Type
10.4.3.2.2. By Sex
10.4.3.2.3. By Product
10.4.3.2.4. By Organ
10.4.3.2.5. By Types of Transplant

11. Middle East and Africa Organ Transplant Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Sex
11.2.3. By Product
11.2.4. By Organ
11.2.5. By Types of Transplant
11.2.6. By Country
11.3. Market Attractiveness Index
11.4. MEA: Country Analysis
11.4.1. South Africa Organ Transplant Market Outlook
11.4.1.1. Market Size & Forecast
11.4.1.1.1. By Value
11.4.1.2. Market Share & Forecast
11.4.1.2.1. By Type
11.4.1.2.2. By Sex
11.4.1.2.3. By Product
11.4.1.2.4. By Organ
11.4.1.2.5. By Types of Transplant
11.4.2. Saudi Arabia Organ Transplant Market Outlook
11.4.2.1. Market Size & Forecast
11.4.2.1.1. By Value
11.4.2.2. Market Share & Forecast
11.4.2.2.1. By Type
11.4.2.2.2. By Sex
11.4.2.2.3. By Product
11.4.2.2.4. By Organ
11.4.2.2.5. By Types of Transplant
11.4.3. UAE Organ Transplant Market Outlook
11.4.3.1. Market Size & Forecast
11.4.3.1.1. By Value
11.4.3.2. Market Share & Forecast
11.4.3.2.1. By Type
11.4.3.2.2. By Sex
11.4.3.2.3. By Product
11.4.3.2.4. By Organ
11.4.3.2.5. By Types of Transplant

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1.1. Novartis
14.2.1.2. Pfizer
14.2.1.3. Transmedics
14.2.1.4. Organ Recovery Systems
14.2.1.5. Sanofi
14.2.1.6. Transonic Systems Inc
14.2.1.7. XVIVO Perfusion
14.2.1.8. Transplant Biomedicals
14.2.1.9. Veloxis Pharmaceuticals A/S
14.2.1.10. Organ Assist B.V
14.2.1.11. Essential Pharmaceuticals LLC.
14.2.1.12. BioLife Solutions, Inc.
14.2.1.13. Lifeline Scientific
14.2.1.14. 21st Century Medicine
14.2.1.15. Preservation solutions Inc
14.2.1.16. GE Healthcare
14.2.1.17. Sandor
14.2.1.18. Glaxosmith Kline
14.2.1.19. AstraZeneca
14.2.1.20. Amgen

15. Strategic Recommendations

16. About Us & Disclaimer
Note: Product cover images may vary from those shown
3 of 3
  • Novartis
  • Pfizer
  • Transmedics
  • Organ Recovery Systems
  • Sanofi
  • Transonic Systems Inc
  • XVIVO Perfusion
  • Transplant Biomedicals
  • Veloxis Pharmaceuticals A/S
  • Organ Assist B.V
  • Essential Pharmaceuticals LLC.
  • BioLife Solutions, Inc.
  • Lifeline Scientific
  • 21st Century Medicine
  • Preservation solutions Inc
  • GE Healthcare
  • Sandor
  • Glaxosmith Kline
  • AstraZeneca
  • Amgen
Note: Product cover images may vary from those shown
Adroll
adroll